Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Bezençon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|August 12, 2025
Discovery and In-Vivo Characterization of K<sub>v</sub>7 Channel Openers through a Phenotypic ApproachRomain Siegrist, Olivier Bezençon, Caroline Deymier, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2017
Discovery and evaluation of Ca<sub>v</sub>3.1-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2017
Discovery and evaluation of Ca<sub>v</sub>3.2-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Design and optimization of new piperidines as renin inhibitorsOlivier Corminboeuf, Olivier Bezençon, Corinna Grisostomi, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Piperidine-based renin inhibitors: upper chain optimizationOlivier Corminboeuf, Olivier Bezençon, Luboš Remeň, et al.
Journal of Medicinal Chemistry|September 1, 2016
Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel BlockersLubos Remen, Olivier Bezençon, Lloyd Simons, et al.
Journal of Medicinal Chemistry|December 10, 2016
Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel BlockersRomain Siegrist, Davide Pozzi, Gaël Jacob, et al.
Bioorganic & Medicinal Chemistry|September 5, 2024
Discovery, synthesis and SAR of 2-acyl-1-biarylmethyl pyrazolidines, dual orexin receptor antagonists designed as fast and short-acting sleeping drugsJean-Philippe Surivet, Melanie Kessler, Catherine Vaillant, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
New classes of potent and bioavailable human renin inhibitorsL'ubos Remen, Olivier Bezençon, Sylvia Richard-Bildstein, et al.
Journal of Medicinal Chemistry|April 11, 2009
Design and preparation of potent, nonpeptidic, bioavailable renin inhibitorsOlivier Bezençon, Daniel Bur, Thomas Weller, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|August 12, 2025
Discovery and In-Vivo Characterization of K<sub>v</sub>7 Channel Openers through a Phenotypic ApproachRomain Siegrist, Olivier Bezençon, Caroline Deymier, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2017
Discovery and evaluation of Ca<sub>v</sub>3.1-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2017
Discovery and evaluation of Ca<sub>v</sub>3.2-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Design and optimization of new piperidines as renin inhibitorsOlivier Corminboeuf, Olivier Bezençon, Corinna Grisostomi, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Piperidine-based renin inhibitors: upper chain optimizationOlivier Corminboeuf, Olivier Bezençon, Luboš Remeň, et al.
Journal of Medicinal Chemistry|September 1, 2016
Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel BlockersLubos Remen, Olivier Bezençon, Lloyd Simons, et al.
Journal of Medicinal Chemistry|December 10, 2016
Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel BlockersRomain Siegrist, Davide Pozzi, Gaël Jacob, et al.
Bioorganic & Medicinal Chemistry|September 5, 2024
Discovery, synthesis and SAR of 2-acyl-1-biarylmethyl pyrazolidines, dual orexin receptor antagonists designed as fast and short-acting sleeping drugsJean-Philippe Surivet, Melanie Kessler, Catherine Vaillant, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
New classes of potent and bioavailable human renin inhibitorsL'ubos Remen, Olivier Bezençon, Sylvia Richard-Bildstein, et al.
Journal of Medicinal Chemistry|April 11, 2009
Design and preparation of potent, nonpeptidic, bioavailable renin inhibitorsOlivier Bezençon, Daniel Bur, Thomas Weller, et al.
Pageof 2